2-(Pyridin-2-yl)-4H-benzo[e][1,3]thiazin-4-one
6,6'-((3,3'-Dimethoxy-[1,1'-biphenyl]-4,4'-diyl)bis(diazene-2,1-diyl))bis(4-amino-5-hydroxynaphthalene-1,3-disulfonic acid), tetrasodium salt
2-(3-(2,4-Difluorophenyl)-4,5-dihydroisoxazol-5-yl)-1-morpholinoethan-1-one
3-(3-Hydroxybenzyl)-5-methylbenzo[d]oxazol-2(3H)-one
4-Iodo-6-phenylpyrimidine
6-(Morpholino(4-(trifluoromethyl)phenyl)methyl)benzo[d][1,3]dioxol-5-ol
Imalumab
MIF-IN-6
4-(3-Carboxyphenyl)pyridine-2,5-dicarboxylic acid
MIF2-IN-1
MKA031
(S)-N-((R)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)-N-methylpyrrolidine-2-carboxamide hydrochloride
MIF-IN-5
MIF-IN-2
(S)-3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate
((1aS,8S,8aR,8bS)-6,8a-Dimethoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl)methyl carbamate
MIF-IN-4 hydrochloride
R110
MIF-IN-1
MIF-IN-3
